We run the raise; you run the science.
Community-round-led, dual-track fundraising for life sciences—paired with physician credibility, trial-site momentum, and a phone-driven conversion engine.
Who this is for
Life-science founders (MedTech, HealthTech, BioTech) planning to raise $250k–$5M in the next 3–8 months who want investor momentum without turning fundraising into a full-time job.
Strong fit
- Targeting $250k–$1M (up to $5M dual-track) in 3–8 months
- Clinical or commercial signal; engaged counsel
- One exec sponsor, 48-hour approvals
Not ideal
- Pre-traction or > $5M with 9–12+ month horizon
- No executive access or slow approvals
Why now
- Dual-track (community + private) adds speed and options
- Pair grants with crowd to amplify validation
- Physician proof and trial partners drive conviction
Common pain points we solve
- Regulatory timing stalls momentum between milestones
- Limited warm network or prior outreach tapped out
- Venture-capital pass loop in a cautious market
- Need physician credibility and trial-site letters
- Founder time consumed by logistics, not science
What you get
Embedded fractional executive
We join your team to own the capital plan and partner strategy (Reg CF and Reg D sequencing; SAFEs or notes).
Business-development engine
Physician endorsements, trial-site letters, payer and strategic introductions. We manufacture the warm network—rather than assume it exists.
Marketing spine
Partner such as Potomac for page, email/webinar funnel, PR light, and paid media. Ad spend is your decision and paid directly by you.
Conversion muscle
Outbound associate calls page visitors and warm leads, re-activates lapsed pledges, and upsells check size.
One quarterback
Weekly pulse, KPIs, and tight coordination across counsel, platform, creatives, and BD.
Risk & compliance
Dataroom readiness and diligence mapping to compress time-to-yes. Founders own narrative compliance through counsel. We avoid transaction-based compensation.
How it works
Phase 0 — Readiness (2 weeks)
Traction audit, value story, capital-stack mapping, timeline and KPIs. Deliverable:Fundraising strategy memo Go / No-Go before moving forward.
Phase 1 — Soft Open (Month 1–2)
Build investor-ready assets; warm the network via webinar and email; pilot business-development lanes. Start outbound call blocks to convert visitors and book one-to-ones.
Phase 2 — Full Launch (Month 3–4)
Public launch and scaled investor acquisition: paid media, webinars, PR light, physician proof, trial-site letters, and outbound upsell calls.
Phase 3 (scale / M&A) available as an add-on.
Pricing approach (plain English)
We keep early cash low and increase retainers only when verified commitments and workload increase. Retainers are tied to pre-agreed traction milestones and scope. This is a retainer ladder aligned to work, not a success fee.
Talk pricing on a quick callLightweight proof
What good looks like in each phase
- Readiness: strategy memo delivered; Go / No-Go within ten business days.
- Soft Open: time-to-first $50k–$100k often within 30–45 days when assets are in place.
- Full Launch: 100–300 targeted touches / month; 1–2 physician validations or trial-site letters.
Cost controls & founder-friendly options
Pilot-light start (45-day cap)
Scope: Readiness + Soft-Open Month 1 (strategy memo, page/email draft, Webinar #1, outbound pilot). Cash: $5k + $5k → $10k cap first 45 days. Move up only when assets are live and ≥ $50k is verified.
Marketing partner gating
Default: partner on from day one. Cost-minimized: defer until ≥ $100k commitments; we run “basic creatives” first.
Advertising spend governor
No paid media until baseline conversion targets are met; start small, scale with return. You control budget.
Right-size policy
If momentum dips, we hold at prior tier or pause by mutual agreement—protects burn and pace.
Ready to see if this is a fit?
Limited founding-cohort spots and pilot discounts through September 30, 2025.
